Egypt's Holding Company for Pharmaceuticals (HoldiPharma) and US-based Dawah Pharma joined forces with Qatari German Medical Devices Company (QG Medical Devices) to localize the medical supplies industry

The sales of foreign companies in the Egyptian pharmaceutical market hiked by 43% year-on-year (YoY) in 2024, Ali Ghamrawy‏, ‏Chairman of the Egyptian Drug Authority (EDA)

Ali Ghamrawy, Chairman of the Egyptian Drug Authority (EDA), held a meeting with a delegation from Johnson & Johnson to discuss the company's policies to expand investments in the Egyptian pharmaceutical market.

The drug shortage crisis in Egypt has been resolved by 98%, Head of the Egyptian Drug Authority (EDA) Ali Ghamrawy announced during a press conference on February 3rd.

The Egyptian Drug Authority (EDA) is considering cooperation with Saudi Arabia’s Ministry of Industry and Mineral Resources in localizing active pharmaceutical ingredients, with the aim of strengthening economic ties and supporting shared strategic goals.

The Egyptian Drug Authority (EDA) will activate a nationwide tracking system for pharmaceuticals starting in the second half (H2) of 2025, the authority’s head Ali Ghamrawy stated.

The ongoing drug shortage crisis in Egypt will be fully resolved within two months.

The Egyptian Drug Authority (EDA) and the Unified Procurement Authority (UPA) have officially launched an initiative aimed at localizing the production of inactive raw materials to ensure the stability of drug supplies and bolster national drug security.

The Egyptian Drug Authority (EDA) has successfully resolved 75% of the ongoing medication shortage.

Prime Minister Mostafa Madbouly met with the Head of the Egyptian Drug Authority (EDA) Ali Ghamrawy to review a report on the availability of medicines in the Egyptian market.

Egypt has allocated EGP 7 billion to ensure the rapid availability of essential medicines and medical supplies in hospitals and pharmacies.

Tenth of Ramadan for Pharmaceutical Industries and Diagnostic Reagents (Rameda) has received approval from the Egyptian Drug Authority (EDA) for price increases on all its major products.

The Egyptian government has committed to addressing the shortage of up to 3,000 types of medicine within three months, acknowledging that some drug prices will increase due to the devaluation of the local currency, Prime Minister Mostafa Madbouly stated in a press conference.

The Egyptian Drug Authority (EDA) has signed a memorandum of understanding (MoU) with the Egyptian Authority for Unified Procurement (UPA) to activate the pharmaceutical track and trace system.

The Egyptian Drug Authority (EDA) has sealed a memorandum of understanding (MoU) with Zambia Medicines Regulatory Authority (ZAMRA) in the field of pharmaceuticals.

The Pharmaceutical Division at the Federation of Egyptian Chambers of Commerce will meet with representatives from the Egyptian Drugs Authority (EDA) next week to discuss the division's demands to increase drug prices in Egypt by up to 50%, the division’s head Ali Aouf told Arab Finance.

EDA said that the move comes within its efforts to achieve institutional excellence, in accordance with the goals of the sustainable development strategy "Egypt's Vision 2030".

The meeting comes in light of the ongoing discussions by the EDA with international bodies and institutions to create partnerships that support the upgrading of the regulatory level in the drug sector.